ArticleFrontiers in oncology2026

Combination therapy with Nifuroxazide and Lenvatinib exerts superior anti-hepatocellular carcinoma effect by enhancing the anti-tumor immune response.

Jing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.